+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biotechnology Media, Sera and Reagents Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828898
  • Report
  • February 2019
  • Region: Global
  • 240 Pages
  • Allied Analytics LLP
Biotechnology Media, Sera And Reagents Market Overview:



The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.

Biotechnology is the branch of science that uses living organisms to make technological advancements and adapt those technologies to various different fields including agriculture, genetic engineering, novel drug developments, and several others. Media and sera find their application in animal tissue culture and plant tissue culture, while reagents are used in various biotechnology applications such as diagnosis, laboratory research, drug development, and others.

Considerable rise in the biotechnological R&D pertaining to the development of biopharmaceuticals has led to an increase in demand for culture media, sera, and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries further boost the market growth. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the market growth. On the contrary, untapped potential of the emerging economies is anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market in the near future.

The biotechnology media, sera and reagents media market is segmented based on type, application, end user, and region. Based on type, the market is divided into media, sera and reagents. The media segment is further bifurcated into lysogeny broth, classical media, serum free media, chemically defined media, specialty media, stem cell media and others. The sera segment is further classified into fetal bovine sera, new born calf sera, and others. Likewise, the reagents segment is further segmented into antibiotics, DNA/RNS isolation reagents, PCR reagents, buffers and others. Based on application, the market is categorized into cancer research, biopharmaceuticals, clinical diagnostics, regenerative medicine & tissue engineering, and others. Based on end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Biotechnology Media, Sera And Reagents Market:

The study provides an in-depth analysis of the global biotechnology media, sera and reagents market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the biotechnology media, sera and reagents market.
Key players and their strategies are provided to understand the competitive outlook of the industry.

Biotechnology Media, Sera And Reagents Key Market Segments:

By Type

Media
Lysogeny Broth
Classical Media
Serum Free Media
Chemically Defined Media
Specialty Media
Stem Cell Media
Others
Sera
Fetal Bovine Sera
New Born Calf Sera
Others
Reagents
Antibiotics
DNA/RNS Isolation Reagents
PCR Reagents
Buffers
Others

By Application

Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Others

By End User

Biotechnology & Pharmaceutical Companies
Academic Institute
Research Laboratory
Others

By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA

Key Market Players

GE Healthcare
Bio-Rad Laboratories Inc.
Merck KGaA (Sigma Aldrich)
Sartorius AG
HiMedia Laboratories Pvt., Ltd
Lonza Group Ltd
Merck & Co., Inc.
Thermofisher Scientific
Corning Incorporated
Becton, Dickinson and Company

The other players in the value chain include (profiles not included in the report)

Avantor Performance Materials, LLC
Caisson Laboratories, Inc
Cell Culture Technologies LLC
Fujifilm Holdings Corporation
Sera Scandia A/S (Biowest)
Vitro Diagnostics, Inc.
Cyagen Biosciences
Frequently Asked Questions about the Global Biotechnology Media, Sera and Reagents Market

What is the estimated value of the Global Biotechnology Media, Sera and Reagents Market?

The Global Biotechnology Media, Sera and Reagents Market was estimated to be valued at $18794.0 million in 2017.

What is the growth rate of the Global Biotechnology Media, Sera and Reagents Market?

The growth rate of the Global Biotechnology Media, Sera and Reagents Market is 7.3%, with an estimated value of $32974.0 million by 2025.

What is the forecasted size of the Global Biotechnology Media, Sera and Reagents Market?

The Global Biotechnology Media, Sera and Reagents Market is estimated to be worth $32974.0 million by 2025.
Note: Product cover images may vary from those shown

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in R&D Investment
3.4.1.2. Increase in advancements associated with cell culture media
3.4.1.3. High demand for media, sera and reagents
3.4.2. Restraints
3.4.2.1. Dearth of skilled professionals
3.4.2.2. Ethical & scientific concerns associated with culture media
3.4.3. Opportunity
3.4.3.1. Untapped potential of the emerging economies
CHAPTER 4: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Media
4.2.1. Key market trends and opportunity
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Lysogeny broth
4.2.4.1. Market size and forecast
4.2.5. Chemically defined media
4.2.5.1. Market size and forecast
4.2.6. Classical media
4.2.6.1. Market size and forecast
4.2.7. Serum-free Media
4.2.7.1. Market size and forecast
4.2.8. Specialty media
4.2.8.1. Market size and forecast
4.2.9. Stem cell media
4.2.9.1. Market size and forecast
4.2.10. Other media
4.2.10.1. Market size and forecast
4.3. Sera
4.3.1. Key market trends and opportunity
4.3.1.1. Market size and forecast
4.3.3. Market analysis, by country
4.3.4. Fetal Bovine Sera Market
4.3.4.1. Market size and forecast
4.3.5. New Born Calf Sera
4.3.5.1. Market size and forecast
4.3.6. others
4.3.6.1. Market size and forecast
4.4. Reagent
4.4.1. Key market trends and opportunity
4.4.1.1. Market size and forecast
4.4.2. Market analysis, by country
4.4.3. Antibiotics
4.4.3.1. Market size and forecast
4.4.4. DNA/RNA Isolation Reagents
4.4.4.1. Market size and forecast
4.4.5. PCR Reagents
4.4.5.1. Market size and forecast
4.4.6. Buffers
4.4.6.1. Market size and forecast
4.4.7. Other reagents
4.4.7.1. Market size and forecast
CHAPTER 5: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Cancer research
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Biopharmaceuticals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Regenerative medicine & tissue engineering
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Other Applications
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Biotechnology & pharmaceutical industry
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Academic institute
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Research laboratory
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: BIOTECHNOLOGY MEDIA, SERA AND REAGENTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America biotechnology media, sera and reagents market size and forecast, by country
7.2.2.1. U.S. market size and forecast, by type
7.2.2.2. U.S. market size and forecast, by application
7.2.2.3. U.S. biotechnology media, sera and reagents market, by end user
7.2.2.4. Canada market size and forecast, by type
7.2.2.5. Canada biotechnology media, sera and reagents market, by application
7.2.2.6. Canada biotechnology media, sera and reagents market, by end user
7.2.2.7. Mexico biotechnology media, sera and reagents market, by type
7.2.2.8. Mexico biotechnology media, sera and reagents market, by application
7.2.2.9. Mexico biotechnology media, sera and reagents market, by end user
7.2.3. North America biotechnology media, sera and reagents market size and forecast, by type
7.2.4. North America biotechnology media, sera and reagents market size and forecast, by application
7.2.5. North America biotechnology media, sera and reagents market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends
7.3.2. Europe biotechnology media, sera and reagents market size and forecast, by country
7.3.2.1. Germany market size and forecast, by type
7.3.2.2. Germany biotechnology media, sera and reagents market, by application
7.3.2.3. Germany biotechnology media, sera and reagents market, by end user
7.3.2.4. France market size and forecast, by type
7.3.2.5. France biotechnology media, sera and reagents market, by application
7.3.2.6. France biotechnology media, sera and reagents market, by end user
7.3.2.7. UK market size and forecast, by type
7.3.2.8. UK biotechnology media, sera and reagents market, by application
7.3.2.9. UK biotechnology media, sera and reagents market, by end user
7.3.2.10. Italy market size and forecast, by type
7.3.2.11. Italy biotechnology media, sera and reagents market, by application
7.3.2.12. Italy biotechnology media, sera and reagents market, by end user
7.3.2.13. Spain biotechnology media, sera and reagents market, by type
7.3.2.14. Spain biotechnology media, sera and reagents market, by application
7.3.2.15. Spain biotechnology media, sera and reagents market, by end user
7.3.2.16. Rest of Europe biotechnology media, sera and reagents market, by type
7.3.2.17. Rest of Europe biotechnology media, sera and reagents market, by application
7.3.2.18. Rest of Europe biotechnology media, sera and reagents market, by end user
7.3.3. Europe biotechnology media, sera and reagents market size and forecast, by type
7.3.4. Europe biotechnology media, sera and reagents market size and forecast, by application
7.3.5. Europe biotechnology media, sera and reagents market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends
7.4.2. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by country
7.4.2.1. Japan biotechnology media, sera and reagents market, by type
7.4.2.2. Japan biotechnology media, sera and reagents market, by application
7.4.2.3. Japan biotechnology media, sera and reagents market, by end user
7.4.2.4. China biotechnology media, sera and reagents market, by type
7.4.2.5. China biotechnology media, sera and reagents market, by application
7.4.2.6. China biotechnology media, sera and reagents market, by end user
7.4.2.7. India biotechnology media, sera and reagents market, by type
7.4.2.8. India biotechnology media, sera and reagents market, by application
7.4.2.9. India biotechnology media, sera and reagents market, by end user
7.4.2.10. Australia biotechnology media, sera and reagents market, by type
7.4.2.11. Australia biotechnology media, sera and reagents market, by application
7.4.2.12. Australia biotechnology media, sera and reagents market, by end user
7.4.2.13. South Korea biotechnology media, sera and reagents market, by type
7.4.2.14. South Korea biotechnology media, sera and reagents market, by application
7.4.2.15. South Korea biotechnology media, sera and reagents market, by end user
7.4.2.16. Taiwan biotechnology media, sera and reagents market, by type
7.4.2.17. Taiwan biotechnology media, sera and reagents market, by application
7.4.2.18. Taiwan biotechnology media, sera and reagents market, by end user
7.4.2.19. Rest of Asia-Pacific biotechnology media, sera and reagents market, by type
7.4.2.20. Rest of Asia-Pacific biotechnology media, sera and reagents market, by application
7.4.2.21. Rest of Asia-Pacific biotechnology media, sera and reagents market, by end user
7.4.3. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by type
7.4.4. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by application
7.4.5. Asia-Pacific biotechnology media, sera and reagents market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends
7.5.2. LAMEA biotechnology media, sera and reagents market size and forecast, by country
7.5.2.1. Brazil biotechnology media, sera and reagents market, by type
7.5.2.2. Brazil biotechnology media, sera and reagents market, by application
7.5.2.3. Brazil biotechnology media, sera and reagents market, by end user
7.5.2.4. Saudi Arabia biotechnology media, sera and reagents market, by type
7.5.2.5. Saudi Arabia biotechnology media, sera and reagents market, by application
7.5.2.6. Saudi Arabia biotechnology media, sera and reagents market, by end user
7.5.2.7. South Africa biotechnology media, sera and reagents market, by type
7.5.2.8. South Africa biotechnology media, sera and reagents market, by application
7.5.2.9. South Africa biotechnology media, sera and reagents market, by end user
7.5.2.10. Rest of LAMEA biotechnology media, sera and reagents market, by type
7.5.2.11. Rest of LAMEA biotechnology media, sera and reagents market, by application
7.5.2.12. Rest of LAMEA biotechnology media, sera and reagents market, by end user
7.5.3. LAMEA biotechnology media, sera and reagents market size and forecast, by type
7.5.4. LAMEA biotechnology media, sera and reagents market size and forecast, by application
7.5.5. LAMEA biotechnology media, sera and reagents market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Production capacity and facility of key companies
8.2. Becton, Dickinson and Company
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments
8.3. Bio-Rad Laboratories Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.4. Corning Incorporated
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.5. GE Healthcare
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments
8.6. HiMedia Laboratories Pvt., Ltd
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Key strategic moves and developments
8.7. Lonza Group Ltd
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. Merck & Co., Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. Sartorius AG
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. Thermo Fisher Scientific Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments
Note: Product cover images may vary from those shown
According to this report titled 'Biotechnology Media, Sera and Reagent Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,' the global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is projected to reach $32,974 million by 2025, growing at a CAGR of 7.3% from 2018 to 2025. North America was the highest revenue contributor in 2017 and would remain the same throughout the forecast period.

Biotechnology is the branch of science that deals with the study of living organisms and their use to make technological innovations. Media is a nutrient growth substance provided in laboratory and research settings for growth, proliferation, maintenance, and storage of microorganisms and other cell types such as stem cells, mammalian, and other cell lines. Different culture media are available in the market for various cell cultures to survive and grow in their incubation environment such as lysogeny broth, serum free media, classical media, chemically defined media among others. In addition, sera are used as additional growth supplement factors owing to the presence of hormones necessary for cell growth, proliferation, and differentiation of cells. Further, reagent is a substance that is used to cause a chemical reaction. Reagents are often used to indicate the presence of another substance.

Based on biotechnology media, sera and reagents market trends by type, the reagent segment accounted for the majority of market share of the global market in 2017. This is attributed to the fact that reagents find their wide applications in all most biotechnological research such as cell culture, biopharmaceutical research and others.

Based on end user, the biotechnology and pharmaceutical company generated the maximum revenue of in 2017. This segment is anticipated to exhibit prominent growth rate, due to significant rise in R&D for the development of biopharmaceutical drugs and cancer research.

Key Findings of the Biotechnology Media, Seraand Reagent Market:
Based on end user, research laboratories accounted for nearly one-third share of the biotechnology media, sera and reagents industry in 2017.
The biopharmaceuticals application segment is anticipated to grow with the highest CAGR throughout the forecast period.
Based on region, North America accounted for nearly two-fifth of the global biotechnology media, sera and reagents market share in 2017.
Asia-Pacific is anticipated to grow at the highest rate in the biotechnology media, sera and reagents market during the analysis period, followed by LAMEA.
North America was the leading revenue contributor to the global market in 2017, owing to increase in healthcare investments by manufacturers, surge in R&D expenditure for the development of biotechnology media, seraand reagent, and growth in prevalence of food allergies. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase awareness & availability about different reagents & media in the market, increase in biotech R&D, and growth in presence of key market players in this region.

The report provides an extensive competitive analysis and profiles of the key market players, such as GE Healthcare, Bio-Rad laboratories Inc., Merck KGaA (Sigma Aldrich), Sartorius AG, HiMedia Laboratories Pvt., Ltd, Lonza Group Ltd, Merck & Co., Inc., Thermofisher Scientific, Corning Incorporated, Becton, Dickinson and Company. The other players in the value chain (not included in the report) are Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, LLC (VWR International, LLC), Caisson Laboratories, Inc., Cell Culture Technologies LLC and Biomol GmbH.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...